Thioltransferase, a small redox protein with thiol-disulfide oxidoreductase
and dehydroascorbate reductase activities, has been reported to be express
ed at higher levels in Adriamycin-resistant MCF-7 human breast tumor cells
(MCF-7 ADR(R)) when compared with Adriamycin sensitive MCF-7 WT (MCF-7 WT)
cells. The present study examined the effects of stably transfecting MCF-7
WT cells with the cDNA for human thioltransferase and the effects of subseq
uent Adriamycin cytotoxicity in the MCF-7 WT transfected cells. All transfe
cted cell lines overexpressing thioltransferase activity were more resistan
t to Adriamycin than untransfected MCF-7 WT cells, supporting the hypothesi
s that increases in thioltransferase expression are related to Adriamycin r
esistance. This resistance was independent of the ability of thioltransfera
se to catalyze reduction of dehydroascorbic acid to ascorbic acid, as the a
ddition of an ascorbate generating derivative, L-ascorbic acid-2-phosphate,
to the media did not additionally increase Adriamycin resistance. (C) 1999
Elsevier Science Inc.